Filters

GABR B3 Antibody

GABR B3 Antibody size: 0.1ml 263

Price 263
Size 0.1ml
Long nameGABR B3 Primary Polyclonal Antibody
Also known asGABR B3 PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenGABR B3
SpecificityThis is a highly specific antibody against GABR B3
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
Immunogen range15-65/473
Subcellular locationExtracellular
SourceThis antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human GABR B3/GABA A Receptor beta 3
Gene ID number2562
Swiss ProtP28472
Tested Applications IF(IHC-P), IHC-P
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500)
Cross reactivity Mouse, Rat, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen Functions also as histamine receptor and mediates cellular responses to histamine, Functions as ligand-gated chloride channel, Functions as receptor for diazepines and various anesthetics, such as pentobarbital, the major inhibitory neurotransmitter in the vertebrate brain, these are bound at a separate allosteric effector binding site, Component of the heteropentameric receptor for GABA
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names GABA(A) receptor subunit beta-3, GABRB3, Gamma-aminobutyric acid receptor subunit beta-3, ECA5
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetGABR B3
Short nameGABR B3 Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameGABR B3 (Antibody to)
Alternative techniqueantibodies

Subscribe to our Newsletter